Rob Buckman

Rob Buckman's AcademicInfluence.com Rankings

Rob Buckman

Philosophy

#1737

World Rank

#3098

Historical Rank

Logic

#7287

World Rank

#9002

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Rob Buckman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Alexander Amiel Buckman was a British doctor of medicine, comedian and author, and president of the Humanist Association of Canada. He first appeared in a Cambridge University Footlights Revue in 1968, and subsequently presented several television and radio programmes about medicine, as well as appearing on comedy programmes such as Just a Minute. He was also the author of many popular books on medicine.

(See a Problem?)

Rob Buckman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. (2000) (2166)
How to break bad news : a guide for health care professionals (1992) (671)
Breaking bad news: why is it still so difficult? (1984) (517)
Oncologists' attitudes toward and practices in giving bad news: an exploratory study. (2002) (347)
Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. (1997) (159)
Breaking bad news: the S-P-I-K-E-S strategy (2005) (145)
Teaching medical students how to break bad news. (1997) (134)
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. (1997) (101)
How To Break Bad News (1992) (86)
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of respon (2010) (75)
Communicating Genetic Test Results to the Family: A Six‐Step, Skills‐Building Strategy (2001) (73)
High-dose cyclophosphamide in small-cell carcinoma of the lung. (1985) (58)
Long‐term survival in myelomatosis; A REPORT TO THE MRC WORKING PARTY ON LEUKAEMIA IN ADULTS (1982) (52)
Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3 (1992) (47)
In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. (1986) (44)
Adjuvant Therapy for Node-Negative Breast Cancer (1989) (33)
Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. (1993) (33)
I Don't Know What to Say: How to Help and Support Someone Who Is Dying (1988) (32)
Breaking bad news : the SPIKE-S strategy (2005) (30)
ELIMINATION OF CARCINOMA CELLS FROM HUMAN BONE MARROW (1982) (29)
Breaking bad news: more than just guidelines. (2006) (29)
A randomized trial of paracentesis plus intraperitoneal tumor necrosis factor-alpha versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma. (1997) (24)
PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY SUCCESSFULLY TREATED WITH CYTOSINE ARABINOSIDE (1976) (24)
Re-evaluating the cost of outpatient cancer chemotherapy. (1987) (22)
Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study. (1995) (19)
Detection of bone metastases in patients with breast cancer. (1982) (17)
Truth telling: yes, but how? (2007) (15)
Doctors can improve on way they deliver bad news, MD maintains. Interview by Evelyne Michaels. (1992) (13)
Practical Plans for Difficult Conversations in Medicine: Strategies That Work in Breaking Bad News (2010) (13)
What you really need to know about cancer : a comprehensive guide for patients and their families (1995) (11)
Eligibility for CPR: is every death a cardiac arrest? (1989) (10)
Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies. (1988) (8)
Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. (1992) (8)
Can We Be Good Without God?: Biology, Behavior, and the Need to Believe (2000) (7)
4. Breaking Bad News: A Six-Step Protocol (1992) (7)
2. Why Breaking Bad News Is Difficult (1992) (6)
Communicating with the Patient (1986) (5)
The invisible effects of therapeutic failure. (2010) (4)
Cancer is a Word, Not a Sentence (2007) (4)
Communicating with cancer patients. (1989) (4)
Phase I-II study of DalCM-P [daily dalteparin (Dal), cyclophosphamide (C) and prednisone (P) and bi-weekly methotrexate (M)] as therapy for metastatic breast cancer (MBC) (2005) (3)
Evaluation of a rosetting method in detection of breast cancer cells. (1984) (3)
What You Really Need to Know about Caring for a Child with Asthma (1999) (2)
Metronomic cyclophosphamide and methotrexate for breast cancer: enhanced efficacy by adding dalteparin and low-dose prednisone? (2011) (2)
How much do the side effects of chemotherapy matter? Patients' attitudes to side effects versus a potential loss of duration of remission. (2010) (2)
Reproducibility of results with homeopathic remedies. (1999) (2)
Words that make a difference: enhancing the "how" in "how we say it". (2006) (2)
Towards a definition of the dying patient: a response to Baylis. (1990) (2)
District cancer physicians. (1987) (2)
Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory colorectal carcinoma. (2009) (1)
INTRATHECAL CYTARABINE IN MULTIPLE SCLEROSIS (1979) (1)
Resuscitation of the terminally ill (1990) (1)
Catfish Man of the Woods: alternative medicine, Appalachian style. (1990) (0)
Who can ever understand? : talking about your cancer (2017) (0)
RADIOTHERAPY AND MEDICAL ONCOLOGY (1981) (0)
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methothrexate, and daily prednisone (DalCMP) as therapy for metastatic breast cancer (MBC). (2010) (0)
A portrait of the doctor and his word processor. (1989) (0)
Handbook of Advanced Cancer Care: Breaking bad news (2003) (0)
Appendix: An Interview Using the Breaking-Bad-News Protocol (1992) (0)
Therapeutic failure: the elephant in the room. (2010) (0)
Practical suggestions for dealing with distress in the patient with head and neck cancer. (2008) (0)
A long time on the verge: The Dread Disease: Cancer and Modern American Culture (1988) (0)
Who Can Ever Understand (1995) (0)
47 – Communicating difficult news supportively: a practical approach (2011) (0)
The charm and the leaf (review of The power of hope: a doctor's perspective) (1999) (0)
Rule One, Drop One (2014) (0)

This paper list is powered by the following services:

Other Resources About Rob Buckman

What Schools Are Affiliated With Rob Buckman?

Rob Buckman is affiliated with the following schools:

University of Toronto